Page last updated: 2024-11-12

2-(4-(3-methyl-2-thienyl)phenyl)propionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(4-(3-methyl-2-thienyl)phenyl)propionic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12769847
SCHEMBL ID4276894
MeSH IDM0272086

Synonyms (12)

Synonym
2-(4-(3-methyl-2-thienyl)phenyl)propionic acid
benzeneacetic acid, a-methyl-4-(3-methyl-2-thienyl)-,(ar)-
SCHEMBL4276894
DTOPKPBTCXKNFF-UHFFFAOYSA-N
2-[4-(3-methyl-2-thienyl)phenyl]propionic acid
HY-101670
CS-6834
mtppa
2-(4-(3-methyl-2-thienyl)phenyl)propanoic acid
2-[4-(3-methylthiophen-2-yl)phenyl]propanoic acid
70991-61-6
AKOS040740854

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" After oral dosing, S-MTPPA was well absorbed from the gastrointestinal tract, to the extent of 97."( Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys.
Esumi, Y; Kitamura, S; Konishi, T; Nishikawa, H; Okada, S; Tatsumi, K, 1998
)
0.3

Dosage Studied

ExcerptRelevanceReference
" In contrast, the R- and S-enantiomers were both detected after the dosing of R-MTPPA."( In vivo studies on chiral inversion and amino acid conjugation of 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs.
Kitamura, S; Konishi, T; Nishikawa, H; Tatsumi, K, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (92.31)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]